Inhibitory and activating receptors involved in immune surveillance by human NK and myeloid cells

We review the structure, cellular distribution, ligand specificity, and function of two emerging types of receptors involved in natural killer (NK) and myeloid cell recognition of other cells: ILT/LIR/MIR and 2B4 receptors. ILT/LIR/MIR receptors are differentially expressed on lymphoid and myeloid cells and two of them, ILT2 and ILT4, recognize HLA class I molecules. Whereas some receptors inhibit, others induce cell activation. 2B4 is broadly expressed on leukocytes, binds CD48, and mediates non‐MHC‐restricted cytotoxicity by NK cells. J. Leukoc. Biol. 66: 718–722; 1999.

[1]  M. Colonna,et al.  Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4. , 1999, Tissue antigens.

[2]  M. Colonna,et al.  Activating interactions in human NK cell recognition: the role of 2B4‐CD48 , 1999, European journal of immunology.

[3]  A. McMichael,et al.  Tetrameric Complexes of Human Histocompatibility Leukocyte Antigen (HLA)-G Bind to Peripheral Blood Myelomonocytic Cells , 1999, The Journal of experimental medicine.

[4]  M. Colonna,et al.  Organization of the leukocyte receptor cluster (LRC) on human Chromosome 19q13.4 , 1999, Mammalian Genome.

[5]  M. Colonna,et al.  The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA‐G1 and HLA‐E molecules co‐expressed on target cells , 1999, European journal of immunology.

[6]  M. Colonna,et al.  Human myeloid cells express an activating ILT receptor (ILT1) that associates with Fc receptor gamma-chain. , 1999, Journal of immunology.

[7]  A. Neil Barclay,et al.  2B4, the Natural Killer and T Cell Immunoglobulin Superfamily Surface Protein, Is a Ligand for CD48 , 1998, The Journal of experimental medicine.

[8]  P. McKay,et al.  Identification of the 2B4 molecule as a counter-receptor for CD48. , 1998, Journal of immunology.

[9]  E. Snyder,et al.  Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C. Maliszewski,et al.  The MHC class I binding proteins LIR‐1 and LIR‐2 inhibit Fc receptor‐mediated signaling in monocytes , 1998, European journal of immunology.

[11]  D. Allen,et al.  The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM , 1998, Nature.

[12]  Jack R. Davis,et al.  Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene , 1998, Nature Genetics.

[13]  G. Ogg,et al.  Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. , 1998, Journal of immunology.

[14]  L. Lanier,et al.  Follow the Leader: NK Cell Receptors for Classical and Nonclassical MHC Class I , 1998, Cell.

[15]  Jun Wu,et al.  Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells , 1998, Nature.

[16]  M. Colonna,et al.  A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells , 1997, The Journal of experimental medicine.

[17]  M. Kubin,et al.  A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. , 1997, Journal of immunology.

[18]  W. Yokoyama.  What Goes Up Must Come Down: The Emerging Spectrum of Inhibitory Receptors , 1997, The Journal of experimental medicine.

[19]  K. Austen,et al.  Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor. , 1997, Journal of immunology.

[20]  M. Kubin,et al.  A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. , 1997, Immunity.

[21]  Eric O Long,et al.  A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors , 1997, Current Biology.

[22]  P. Leibson.  Signal transduction during natural killer cell activation: inside the mind of a killer. , 1997, Immunity.

[23]  Manfred Brockhaus,et al.  A Novel Inhibitory Receptor (ILT3) Expressed on Monocytes, Macrophages, and Dendritic Cells Involved in Antigen Processing , 1997, The Journal of experimental medicine.

[24]  B. Cocks,et al.  SLAM and its role in T cell activation and Th cell responses , 1997, Immunology and cell biology.

[25]  M. Colonna,et al.  Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: Structural evidence for new stimulatory and inhibitory pathways , 1997, European journal of immunology.

[26]  S. Christmas,et al.  NK cells and reproduction. , 1997, Immunology today.

[27]  S. Davis,et al.  The structure and ligand interactions of CD2: implications for T-cell function. , 1996, Immunology today.

[28]  W. Yokoyama.  Natural killer cell receptors. , 1998, Current opinion in immunology.

[29]  M. Bennett,et al.  Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. , 1993, Journal of immunology.

[30]  A. Purohit,et al.  A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. , 1993, Journal of immunology.